Sign In
Buy RDY
$13.02
-0.0100 (-0.0767%)
At Close: Jun 03, 2026
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
11:17am, Monday, 06'th Mar 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
12:03pm, Friday, 03'rd Mar 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Dr. Reddy's Laboratories: Positive Q3 Results, Growth Supportive Of Buy
07:31am, Thursday, 16'th Feb 2023
Growth in key emerging markets, including India and Russian footprint. Positive Q3 FY23 results with top–bottom line growth. Solid FCF conversion and returns on capital.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
11:18am, Wednesday, 08'th Feb 2023
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The 3 Most Undervalued Stocks in India for Your February Buy List
06:25pm, Tuesday, 31'st Jan 2023
The Indian markets have been in focus with the recent Hindenburg Research report on the Adani Group. The report alleges that the group has pulled off the “largest con in corporate history.
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates
06:36pm, Friday, 27'th Jan 2023 Zacks Investment Research
Dr. Reddy's (RDY) beat earnings and revenues in the fiscal third quarter, driven by growth in the United States and Russian markets.
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates
03:03pm, Friday, 27'th Jan 2023
Dr. Reddy's (RDY) beat earnings and revenues in the fiscal third quarter, driven by growth in the United States and Russian markets.
Dr. Reddy's Laboratories Limited (RDY) Q3 2023 Earnings Call Transcript
02:26pm, Wednesday, 25'th Jan 2023
Dr. Reddy's Laboratories Limited (NYSE:RDY ) Q3 2023 Earnings Conference Call January 25, 2023 8:30 AM ET Company Participants Richa Periwal - IR Parag Agarwal - CFO Erez Israeli - CEO Amit Agarwal -
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
02:40pm, Friday, 13'th Jan 2023 Zacks Investment Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TEVA Shares Rise on Broad Support for Opioids Settlement
03:03pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement.
New Strong Buy Stocks for January 10th
12:33pm, Tuesday, 10'th Jan 2023 Zacks Investment Research
STNE, JD, VSH, MOMO and RDY have been added to the Zacks Rank #1 (Strong Buy) List on January 10 , 2023.
New Strong Buy Stocks for January 10th
09:02am, Tuesday, 10'th Jan 2023
STNE, JD, VSH, MOMO and RDY have been added to the Zacks Rank #1 (Strong Buy) List on January 10 , 2023.
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
02:40pm, Monday, 09'th Jan 2023 Zacks Investment Research
Here is how McKesson (MCK) and Doctor Reddy's (RDY) have performed compared to their sector so far this year.
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
01:19pm, Monday, 09'th Jan 2023 Zacks Investment Research
Teva Pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that the
Doctor Reddy's (RDY) Gains But Lags Market: What You Should Know
11:15pm, Thursday, 29'th Dec 2022 Zacks Investment Research
Doctor Reddy's (RDY) closed the most recent trading day at $52.12, moving +0.77% from the previous trading session.
